Arcutis Biotherapeutics, Inc. ARQT Business Segments — Other Income (Expense)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s business segments — other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s business segments — other income (expense)?
- Arcutis Biotherapeutics, Inc. (ARQT) reported business segments — other income (expense) of -$20K in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s business segments — other income (expense) changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s business segments — other income (expense) decreased by 110.4% year-over-year, from $193K to -$20K.
- What does business segments — other income (expense) mean?
- Includes non-operating gains or losses that do not fit into standard categories like interest or taxes, such as foreign exchange impacts or asset disposals. This metric captures the net impact of peripheral financial events on the segment's bottom line.